HER2 Status Determined by 2007 and 2013 ASCO/CAP Criteria, Respectively... | Download Table
Second act for HER2, in gastric cancers - CAP TODAY
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/ CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer | Virchows Archiv
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/ CAP ISH group 4 breast cancer | npj Breast Cancer
Breast cancer biomarkers, and a new clinical category for HER2 expression | Medical Laboratory Observer
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines.,JAMA Oncology - X-MOL
PPT - HER2 Testing in Breast Cancer: 2013 ASCO/CAP HER2 Guideline Update PowerPoint Presentation - ID:6109259
ASCO 2020: HER2 Reclassification - Agendia Inc.
What's New in the 2020 Update to the CAP/ASCO ER/PR Testing Guidelines in Breast Cancer?
![PDF] HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical](https://d3i71xaburhd42.cloudfront.net/c7289407931d6ff274350f21b4024900edadc66e/2-Figure1-1.png "PDF] HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical")
PDF] HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical
HER2 IHC and Her2 FISH Criteria Under the 2007 and the 2013 ASCO/CAP... | Download Table
Implementation of the 2018 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2/neu Assessment by FISH in breast cancers: predicted impact in a single institutional cohort | Modern Pathology
ASCO/CAP Guidelines To Determine ER Status May Need Rehaul - General Surgery News
Introduction:
Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows | BMC Medical Genomics | Full Text
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update | Journal of Clinical Oncology
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer | Anticancer Research
Mapping knowledgebase-specific evidence codes to AMP/ASCO/CAP... | Download Table
Summary of ASCO/CAP HER2 testing recommendations 2007 and 2013 | Download Table
CACSV
Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents - Modern Pathology
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update | Journal of Clinical Oncology
![PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/747f72db6685fa520b07391fb016bac6754d7633/9-Figure3-1.png "PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar")
PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar
2018 ASCO/CAP summary recommendations [original recommendations and... | Download Scientific Diagram
Q&A column - CAP TODAY
Updated (2018) ASCO/CAP Guidelines for HER2 Testing in Breast Cancer - Insights
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia - ScienceDirect
